CCR8 and colitis: In this setting, CCL8 treatment resulted in increased colitis even in the absence of CCR8 (Figures 3E, F) supporting the concept that this chemokine seemingly at least under these particular experimental settings employs other CCR8 independent signal transduction pathways to amplify intestinal inflammation in vivo.